COMPARISON OF CILOSTAZOL-BASED TRIPLE ANTIPLATELET THERAPY VERSUS DUAL ANTIPLATELET THERAPY FOR OUTCOMES OF BELOW-THE KNEE ENDOVASCULAR INTERVENTION IN PATIENTS WITH CRITICAL LIMB ISCHEMIA (TAP CLI STUDY):